Click on a filter below to refine your search. Remove a filter to broaden your search.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening